-transparent.png){kind=logo}
Data are presented demonstrating that adenylate kinase (AK; EC 2.7.4.3) is an oncodevelopmental enzyme in the prostate of Copenhagen rats. We selected the Dunning tumor (dorsal rat prostate) as a model system because it most nearly approximates the human pathology. Four sublines of the tumor (R3327-H, R3327-AT, MAT Lu, and MAT LyLu) were studied. The tumor sublines were maintained as solid tumors in syngeneic rats and as monolayers in tissue culture. AK activity appeared in conjunction with malignant transformation of the dorsal prostate. We also determined the normal developmental enzyme pattern: AK was present in prostates of newborns, but was undetectable in prostates of adults. However, AK increased after castration. Therefore, we propose AK as a potential oncofetal tumor marker in prostatic cancer.
M Hall, and
D D Mickey, and
A S Wenger, and
L M Silverman
January 1980,
Progress in clinical and biological research,
M Hall, and
D D Mickey, and
A S Wenger, and
L M Silverman
January 1977,
Cancer treatment reports,
M Hall, and
D D Mickey, and
A S Wenger, and
L M Silverman
January 1990,
Transfusion,
M Hall, and
D D Mickey, and
A S Wenger, and
L M Silverman
July 1977,
Investigative urology,
M Hall, and
D D Mickey, and
A S Wenger, and
L M Silverman
January 1997,
Journal of clinical laboratory analysis,
M Hall, and
D D Mickey, and
A S Wenger, and
L M Silverman
November 2004,
Carcinogenesis,
M Hall, and
D D Mickey, and
A S Wenger, and
L M Silverman
February 1977,
Surgery,
M Hall, and
D D Mickey, and
A S Wenger, and
L M Silverman
September 1996,
Photochemistry and photobiology,
M Hall, and
D D Mickey, and
A S Wenger, and
L M Silverman
January 1992,
Journal of the National Cancer Institute. Monographs,
M Hall, and
D D Mickey, and
A S Wenger, and
L M Silverman
January 1977,
Transactions of the American Association of Genito-Urinary Surgeons,
